Leaflet NEORECORMON 30000UI / 0.6ml solution for injection in pre-filled syringe


Indicated for: anemia

Substance: epoetin beta (erythropoiesis-stimulating agent)

ATC: B03XA01 (Blood and blood forming organs | Other antianemic preparations)

Epoetin beta is a medication used to treat anemia, especially in patients with chronic kidney failure or those undergoing dialysis. This medicine stimulates the production of red blood cells, helping to increase hemoglobin levels and reduce symptoms of fatigue. Epoetin beta is usually administered by subcutaneous or intravenous injection, as directed by the doctor.

Treatment with epoetin beta is closely monitored by the medical team, as the dose must be adjusted based on the body's response and hemoglobin levels. It is important for patients to strictly follow the doctor's recommendations and have regular blood tests to prevent complications.

Side effects may include high blood pressure, headaches, joint pain, or reactions at the injection site. In rare cases, severe allergic reactions or an increased risk of blood clots may occur.

Epoetin beta is an essential treatment for patients with severe anemia, but it requires constant medical supervision to ensure the therapy's effectiveness and safety. Open communication with the doctor is crucial for proper management of the treatment.

General data about NEORECORMON 30000UI / 0.6ml

  • Substance: epoetin beta
  • Date of last drug list: 01-05-2026
  • Commercial code: W64397001
  • Concentration: 30000UI / 0.6ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Packing volume: 0,6ml
  • Product type: original
  • Price: 1190.39 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ROCHE PHARMA AG - GERMANIA
  • Holder: ROCHE REGISTRATION GMBH - GERMANIA
  • Number: 31/2004/45
  • Shelf life: 2 years

Concentrations available for epoetin beta

  • 10000UI/0.6ml
  • 10000UI/ml
  • 1000UI/0.3ml
  • 1000UI/ml
  • 20000UI/0.6ml
  • 20000UI/ml
  • 2000UI/0.3ml
  • 30000UI/0.6ml
  • 3000I/0.3ml
  • 4000UI/0.3ml
  • 50000UI/ml
  • 5000UI/0.3ml
  • 500UI/0.3ml
  • 60000UI/ml
  • 6000UI/0.3ml
PDF icon EMA leaflet
Published: 04/11/2008
Updated: 02/05/2025

Compensation lists for NEORECORMON 30000UI / 0.6ml Egis

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price

Copayment

Patient

1190.39 RON

1190.39 RON

0.00 RON

G25 (C1) - Chronic renal failure

Price

Copayment

Patient

1190.39 RON

1190.39 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

1190.39 RON

1190.39 RON

0.00 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price

Copayment

Patient

1190.39 RON

1190.39 RON

0.00 RON